EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience

Documenti analoghi

• Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities
  di: Jain, Preetesh, et al.
  Pubblicazione: (2013)
• Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
  di: Quintás-Cardama, Alfonso, et al.
  Pubblicazione: (2009)
• The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
  di: Jabbour, Elias, et al.
  Pubblicazione: (2011)
• Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
  di: Verma, Dushyant, et al.
  Pubblicazione: (2011)
• The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure
  di: Jabbour, Elias, et al.
  Pubblicazione: (2013)